
Novel curcumin analogs to overcome EGFR–TKI lung adenocarcinoma drug resistance and reduce EGFR–TKI-induced GI adverse effects
Author(s) -
Koji Wada,
Jen Yi Lee,
Hsin Yi Hung,
Qian Shi,
Lin Liu,
Yu Zhao,
Masuo Goto,
PanChyr Yang,
Sheng Chu Kuo,
Hui-Wen Chen,
Kuo Hsiung̀ Lee
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/nerx-zb60
Subject(s) - curcumin , drug , pharmacology , adverse effect , medicine